All Stories

  1. Efficient Delivery of CRISPR-Cas9 RNP Complexes with Cyclodextrin-Based Nanosponges for Enhanced Genome Editing: TILD-CRISPR Integration

    Article • International Journal of Molecular Sciences, November 2025, MDPI AG

    Arash Arashkia

  2. The first case of Mpox infection in Iran during the 2022 outbreak

    Article • The Journal of Infection in Developing Countries, September 2024, Journal of Infection in Developing Countries

    Arash Arashkia

  3. Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro

    Article • Iranian Biomedical Journal, November 2023, Apex Publishing

    Arash Arashkia

  4. Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice

    Article • Microbial Pathogenesis, February 2022, Elsevier

    Arash Arashkia

  5. The evolving direct and indirect platforms for the detection of SARS-CoV-2

    Article • Journal of Virological Methods, February 2022, Elsevier

    Arash Arashkia

  6. Quantitative evaluation of PpSP15-LmSTI1 fusion gene expression following transfection with an alphavirus-derived self-amplifying mRNA and conventional DNA vaccine platforms

    Article • Molecular and Cellular Probes, October 2021, Elsevier

    Arash Arashkia

  7. Bi/tri-specific antibodies (HN-Fc-CD16 and HN-Fc-IL-15-CD16) cross-linking natural killer (NK)-CD16 and Newcastle Disease Virus (NDV)-HN, enhanced NK activation for cancer immunotherapy

    Article • International Immunopharmacology, July 2021, Elsevier

    Arash Arashkia

  8. The Inclusive Review on SARS-CoV-2 Biology, Epidemiology, Diagnosis, and Potential Management Options

    Article • Current Microbiology, February 2021, Springer Science + Business Media

    Arash Arashkia

  9. VP7 and VP4 genotypes of rotaviruses cocirculating in Iran, 2015 to 2017: Comparison with cogent sequences of Rotarix and RotaTeq vaccine strains before their use for universal mass vaccination

    Article • Journal of Medical Virology, December 2019, Wiley

    Arash Arashkia

  10. Expression analysis data of BCL11A and γ-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion

    Article • Data in Brief, December 2019, Elsevier

    Arash Arashkia

  11. Molecular analysis of human adenoviruses in hospitalized children <5 years old with acute gastroenteritis in Tehran, Iran

    Article • Journal of Medical Virology, July 2019, Wiley

    Arash Arashkia

  12. Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone

    Article • Viral Immunology, April 2018, Mary Ann Liebert Inc

    Arash Arashkia

  13. Differential Maturation of miR-17 ~ 92 Cluster Members in Human Cancer Cell Lines

    Article • Applied Biochemistry and Biotechnology, February 2017, Springer Science + Business Media

    Arash Arashkia

  14. Immuno-Stimulating Peptide Derived from HMGB1 is More Effective Than the N-Terminal Domain of Gp96 as an Endogenous Adjuvant for Improvement of Protein Vaccines

    Article • Protein & Peptide Letters, January 2017, Bentham Science Publishers

    Azam Bolhassani, Arash Arashkia

  15. Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies

    Article • Research in Pharmaceutical Sciences, January 2017, Medknow

    Arash Arashkia

  16. In vitro expression of HPV16 E7 linked to HMGB1 immunoadjuvant in mammalian cells

    Article • Bratislava Medical Journal, January 2017, AEPress, s.r.o.

    Arash Arashkia

  17. A novel dendritic cell-targeted lentiviral vector, encoding Ag85A-ESAT6 fusion gene of Mycobacterium tuberculosis, could elicit potent cell-mediated immune responses in mice

    Article • Molecular Immunology, July 2016, Elsevier

    Arash Arashkia

  18. Isolation, cloning, and expression of E. coli BirA gene for biotinylation applications

    Article • Advanced Biomedical Research, January 2015, Medknow

    Arash Arashkia

  19. Modulation of hepatitis C virus core DNA vaccine immune responses by co-immunization with CC-chemokine ligand 20 (CCL20) gene as immunoadjuvant

    Article • Molecular Biology Reports, June 2014, Springer Science + Business Media

    Arash Arashkia

  20. Expression of recombinant Hepatitis C virus (HCV) ore, E1 and E2 proteins by the baculovirus expression vector system

    Article • African Journal of Microbiology Research, May 2012, Academic Journals

    Arash Arashkia

  21. Presence of plus-strand HCV RNA in serum and PBMCs as an indicator for relapse and resistance to IFN therapy in patients infected by HCV

    Article • Future Virology, March 2012, Future Medicine

    Arash Arashkia

  22. Construction of HCV-polytope vaccine candidates harbouring immune-enhancer sequences and primary evaluation of their immunogenicity in BALB/c mice

    Article • Virus Genes, October 2009, Springer Science + Business Media

    Arash Arashkia

  23. Polytope DNA Vaccine Development Against Hepatitis C Virus: A Streamlined Approach from In Silico Design to In Vitro and Primary In Vivo Analyses in BALB/c Mice

    Article • Protein & Peptide Letters, July 2009, Bentham Science Publishers

    Arash Arashkia